Filing Flows

Filing Flows › Johnson & Johnson (JNJ) › Stock forecast & fair value

Johnson & Johnson (JNJ) stock forecast and fair value

Johnson & Johnson (JNJ) trades at $276.22. 22 analysts' median price target is $280.50 (+2%), from $190.00 to $320.00. Across 17 valuation methods the middle fair value is $145.04 (-47%).

Price$276.22
Median target$280.50
Fair value, middle$145.04
EPS beat rate75%
Johnson & Johnson fair value by method (price $276.22)Johnson & Johnson fair value by method (price $276.22)low – highpoint estimateP/E vs peers$118.53P/E vs peers, weighted$229.17P/E vs peers, matched$277.59EV/Sales vs peers$145.04EV/Sales vs peers, weighted$196.07EV/Sales vs peers, matched$160.32Residual income$52.33Analysts' price targets$279.41Our model (Rotation forecast)$280.23Owner earnings capitalized$187.37

Fair value by method

MethodLowPointHighvs price
P/E vs peers$86.26$118.53$285.13-57%
P/E vs peers, weighted$111.64$229.17$345.57-17%
P/E vs peers, matched$189.71$277.59$551.08+0.5%
EV/Sales vs peers$79.06$145.04$307.40-47%
EV/Sales vs peers, weighted$108.48$196.07$371.39-29%
EV/Sales vs peers, matched$115.12$160.32$286.74-42%
Residual income$50.34$52.33$54.44-81%
Analysts' price targets$190.00$279.41$320.00+1%
Our model (Rotation forecast)$219.60$280.23$357.61+1%
Owner earnings capitalized$151.06$187.37$246.68-32%

Johnson & Johnson's latest quarter

Johnson & Johnson, Q3 2026: revenue $25.4B (+6% year over year), operating margin 0.1%, net earnings $210M, operating cash flow $7.7B. The chart follows the revenue to costs, profit and cash.

Questions

What is the price target for JNJ stock?

The median of 22 analysts' 12-month targets is $280.50, +2% from $276.22; the range is $190.00 to $320.00. The average rating is buy.

What is Johnson & Johnson's fair value?

The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between $0.00 and $286.98, with a middle value of $145.04 against a price of $276.22. Each method's assumptions are on the page.

Does Johnson & Johnson usually beat earnings estimates?

It beat the consensus EPS estimate in 75% of the quarters on record.

Is JNJ stock a buy?

Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.